Order Article Reprints

Hernández-Pedro N, Arroyo-Hernández M, Barrios-Bernal P, Romero-Nuñez E, Sosa-Hernandez VA, Ávila-Ríos S, Maravillas-Montero JL, Pérez-Padilla R, de Miguel-Perez D, Rolfo C, et al. Impact of Tyrosine Kinase Inhibitors on the Immune Response to SARS-CoV-2 Vaccination in Patients with Non-Small Cell Lung Cancer. Vaccines. 2023; 11(10):1612. https://doi.org/10.3390/vaccines11101612

Hernández-Pedro, Norma, Marisol Arroyo-Hernández, Pedro Barrios-Bernal, Eunice Romero-Nuñez, Victor A. Sosa-Hernandez, Santiago Ávila-Ríos, José Luis Maravillas-Montero, Rogelio Pérez-Padilla, Diego de Miguel-Perez, Christian Rolfo, and et al. 2023. "Impact of Tyrosine Kinase Inhibitors on the Immune Response to SARS-CoV-2 Vaccination in Patients with Non-Small Cell Lung Cancer" Vaccines 11, no. 10: 1612. https://doi.org/10.3390/vaccines11101612

Hernández-Pedro, N., Arroyo-Hernández, M., Barrios-Bernal, P., Romero-Nuñez, E., Sosa-Hernandez, V. A., Ávila-Ríos, S., Maravillas-Montero, J. L., Pérez-Padilla, R., de Miguel-Perez, D., Rolfo, C., & Arrieta, O. (2023). Impact of Tyrosine Kinase Inhibitors on the Immune Response to SARS-CoV-2 Vaccination in Patients with Non-Small Cell Lung Cancer. Vaccines, 11(10), 1612. https://doi.org/10.3390/vaccines11101612